Home>Media>Newsroom Media Newsroom - 2024 Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023-24 14 FEB 2024 | READ MORE Glenmark partners with Pfizer to launch Abrocitinib in India 31 JAN 2024 | READ MORE Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance ‐ ‘Ichnos Glenmark Innovation’ 30 JAN 2024 | READ MORE Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World 25 JAN 2024 | READ MORE Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India 03 JAN 2024 | READ MORE Year – 2024 Year – 2023 Year – 2022 Year – 2021 Year – 2020 Year – 2019 Year – 2018 Year – 2017 Year – 2016 Year – 2015